These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 30522964)
101. Colonic Proteome Signature in Immunoproteasome-Deficient Stressed Mice and Its Relevance for Irritable Bowel Syndrome. Goichon A; Bahlouli W; Ghouzali I; Chan P; Vaudry D; Déchelotte P; Ducrotté P; Coëffier M J Proteome Res; 2019 Jan; 18(1):478-492. PubMed ID: 30475625 [TBL] [Abstract][Full Text] [Related]
102. Antenatal PPAR-γ agonist pioglitazone stimulates fetal lung maturation equally in males and females. Lee C; Sakurai R; Shin E; Wang Y; Liu J; Rehan VK Am J Physiol Lung Cell Mol Physiol; 2020 Sep; 319(3):L435-L443. PubMed ID: 32579381 [TBL] [Abstract][Full Text] [Related]
103. Centrally administered butyrate improves gut barrier function, visceral sensation and septic lethality in rats. Okumura T; Nozu T; Ishioh M; Igarashi S; Kumei S; Ohhira M J Pharmacol Sci; 2021 Aug; 146(4):183-191. PubMed ID: 34116731 [TBL] [Abstract][Full Text] [Related]
104. Centrally administered GLP-1 analogue improves intestinal barrier function through the brain orexin and the vagal pathway in rats. Funayama T; Nozu T; Ishioh M; Igarashi S; Sumi C; Saito T; Toki Y; Hatayama M; Yamamoto M; Shindo M; Tanabe H; Okumura T Brain Res; 2023 Jun; 1809():148371. PubMed ID: 37076092 [TBL] [Abstract][Full Text] [Related]
105. Brain histamine improves colonic hyperpermeability through the basal forebrain cholinergic neurons, adenosine A2B receptors and vagus nerve in rats. Ishioh M; Nozu T; Miyagishi S; Igarashi S; Funayama T; Ueno N; Okumura T Biochem Pharmacol; 2024 Jun; 224():116201. PubMed ID: 38608783 [TBL] [Abstract][Full Text] [Related]
106. Ischemia reperfusion-induced metastasis is resistant to PPARγ agonist pioglitazone in a murine model of colon cancer. Tashiro Y; Nishino H; Higuchi T; Sugisawa N; Fukuda Y; Yamamoto J; Inubushi S; Aoki T; Murakami M; Singh SR; Bouvet M; Hoffman RM Sci Rep; 2020 Oct; 10(1):18565. PubMed ID: 33122687 [TBL] [Abstract][Full Text] [Related]
107. Oral Phyto-thymol ameliorates the stress induced IBS symptoms. Subramaniyam S; Yang S; Diallo BN; Fanshu X; Lei L; Li C; Tastan Bishop Ö; Bhattacharyya S Sci Rep; 2020 Aug; 10(1):13900. PubMed ID: 32807797 [TBL] [Abstract][Full Text] [Related]
108. Deciphering the multicomponent synergy mechanisms of SiNiSan prescription on irritable bowel syndrome using a bioinformatics/network topology based strategy. Li B; Rui J; Ding X; Chen Y; Yang X Phytomedicine; 2019 Oct; 63():152982. PubMed ID: 31299593 [TBL] [Abstract][Full Text] [Related]
110. Visceral analgesics: drugs with a great potential in functional disorders? Bradesi S; Herman J; Mayer EA Curr Opin Pharmacol; 2008 Dec; 8(6):697-703. PubMed ID: 18786654 [TBL] [Abstract][Full Text] [Related]
112. Pioglitazone, Nuclear Receptors, and Aerodigestive Prevention. Ondrey FG Cancer Prev Res (Phila); 2019 Oct; 12(10):641-644. PubMed ID: 31537582 [TBL] [Abstract][Full Text] [Related]
113. Pain matrix shift in the rat brain following persistent colonic inflammation revealed by voxel-based statistical analysis. Huang T; Okauchi T; Hu D; Shigeta M; Wu Y; Wada Y; Hayashinaka E; Wang S; Kogure Y; Noguchi K; Watanabe Y; Dai Y; Cui Y Mol Pain; 2019; 15():1744806919891327. PubMed ID: 31709891 [TBL] [Abstract][Full Text] [Related]
114. Correction: MicroRNA-29a increased the intestinal membrane permeability of colonic epithelial cells in irritable bowel syndrome rats. Chao G; Wang Y; Zhang S; Yang W; Ni Z; Zheng X Oncotarget; 2018 Mar; 9(21):15816. PubMed ID: 29645021 [TBL] [Abstract][Full Text] [Related]
115. Erratum: The Protective Effect of Choi SI; Kim N; Nam RH; Jang JY; Kim EH; Ha S; Kang K; Lee W; Choi H; Kim YR; Seok YJ; Shin CM; Lee DH J Cancer Prev; 2023 Dec; 28(4):219. PubMed ID: 38205366 [TBL] [Abstract][Full Text] [Related]
116. Pioglitazone: A prudent prescription. Kalra S; Dhamija P; Sahay R Indian J Endocrinol Metab; 2013 May; 17(3):370-2. PubMed ID: 23869291 [No Abstract] [Full Text] [Related]
117. Mechanisms of Probiotic VSL#3 in a Rat Model of Visceral Hypersensitivity Involves the Mast Cell-PAR2-TRPV1 Pathway. Li YJ; Dai C; Jiang M Dig Dis Sci; 2019 May; 64(5):1182-1192. PubMed ID: 30560330 [TBL] [Abstract][Full Text] [Related]
118. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T Eur J Pharmacol; 2019 Jun; 852():198-206. PubMed ID: 30935894 [TBL] [Abstract][Full Text] [Related]
119. The Role of Intestinal Microbiota and Mast Cell in a Rat Model of Visceral Hypersensitivity. Li YJ; Li J; Dai C J Neurogastroenterol Motil; 2020 Sep; 26(4):529-538. PubMed ID: 32989188 [TBL] [Abstract][Full Text] [Related]
120. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome. Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T Sci Rep; 2019 Dec; 9(1):19603. PubMed ID: 31862976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]